Target intelligence / Profile preview

Cytosolic 5'-nucleotidase 1B (NT5C1B)

Target
NT5C1B
Molecular classification
Enzyme, specifically a cytosolic 5'-nucleotidase
01

Overview

Cytosolic 5'-nucleotidase 1B (NT5C1B) is an intracellular enzyme that catalyzes the hydrolysis of nucleotide monophosphates, predominantly AMP, to release inorganic phosphate and the corresponding nucleoside—typically adenosine. As a cytosolic member of the 5'-nucleotidase family, it controls the intracellular levels of AMP and contributes to the regulation of cellular nucleotide pools and adenosine metabolism. The enzyme plays a housekeeping metabolic role rather than being a key drug target or clinical biomarker. Mutations or alterations in NT5C1B activity have been associated with rare genetic syndromes, such as Laurence-Moon syndrome and pontocerebellar hypoplasia, but NT5C1B is not currently a focus of targeted therapeutics, and there are no known drugs that interact specifically with this protein. It is considered functionally important for nucleotide turnover and purine metabolism in various tissues.

Other names
Cytosolic 5'-nucleotidase IBAIRPFKSG85cN1BcN-IBCN-IBCN1BAutoimmune infertility-related proteintesticular tissue protein Li 1
02

Mechanism of action

Not applicable (no current drugs directly targeting this enzyme; mechanism is hydrolysis of nucleotide monophosphates)

03

Biological functions

Nucleotide monophosphate hydrolysisAMP catabolic processAdenosine production and metabolismRegulation of adenosine levelsNucleotide and nucleoside metabolism
04

Disease associations

Laurence-Moon syndromePontocerebellar hypoplasia, type 9Other (not a well-established or common disease target)

Beyond the preview

Go deeper on Cytosolic 5'-nucleotidase 1B (NT5C1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytosolic 5'-nucleotidase 1B (NT5C1B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call